EPO Patent Publication: Rock Hyrax IPSC Generation Methods
Summary
The European Patent Office has published a patent application (EP2026030659A1) detailing methods for generating induced pluripotent stem cells (IPSC) from rock hyrax. The publication date is March 18, 2026, and it includes IPC classifications related to cell culture and genetic manipulation.
What changed
The European Patent Office (EPO) has published patent application EP2026030659A1, titled 'Methods of generating rock hyrax IPSC'. The publication date is March 18, 2026. The application includes IPC classifications C12N 5/00, A01K 67/0275, and C12N 15/113, indicating its relevance to cell culture, animal breeding, and genetic engineering.
This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. However, companies involved in biotechnology, stem cell research, or pharmaceutical development should note this filing for potential intellectual property considerations and competitive intelligence. The inventors have not yet filed their designation.
Source document (simplified)
METHODS OF GENERATING ROCK HYRAX IPSC
Publication EP2026030659A1 Kind: A1 Mar 18, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
C12N 5/00 20060101AFI20260208BHEP A01K 67/0275 20240101ALI20260208BHEP C12N 15/113 20100101ALI20260208BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.